FDA Import Refusal 1FX-2130288-0/10002/1 — URMILIFE SCIENCES LLP
The FDA refused shipment 1FX-2130288-0/10002/1 from URMILIFE SCIENCES LLP (India) on Aug 13, 2026. The refused product falls under Drugs and Biologics — GLUCAGON (ANTI-DIABETIC). Cited charges: 118,3280,3896,75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Aug 13, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PBH10 GLUCAGON (ANTI-DIABETIC)
- Charges
- 118,3280,3896,75